Figure 2.
Outcomes for patients transplanted for malignancy receiving BuCy (n = 773; solid red line) or BuFlu (n = 205; dashed blue line). (A) Transplant-related mortality. (B) Disease relapse. (C) Disease-free survival. (D) OS.
Outcomes for patients transplanted for malignancy receiving BuCy (n = 773; solid red line) or BuFlu (n = 205; dashed blue line). (A) Transplant-related mortality. (B) Disease relapse. (C) Disease-free survival. (D) OS.
